BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He L, Lv Y, Song Y, Zhang B. The prognosis comparison of different molecular subtypes of breast tumors after radiotherapy and the intrinsic reasons for their distinct radiosensitivity. Cancer Manag Res. 2019;11:5765-5775. [PMID: 31303789 DOI: 10.2147/cmar.s213663] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Ma L. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer. BMC Cancer 2021;21:965. [PMID: 34454451 DOI: 10.1186/s12885-021-08642-6] [Reference Citation Analysis]
2 Luz FAC, Araújo RA, Silva MJB. Decreased Survival of Invasive Ductal Breast Cancer Patients With Two Macrometastatic Lymph Nodes Among Few Resected Ones: Should Current Sentinel-Lymph-Node Guidelines Be Revised? Front Oncol 2021;11:669890. [PMID: 34350113 DOI: 10.3389/fonc.2021.669890] [Reference Citation Analysis]
3 Xu L, Zhou C, Qiu J, Lv Q, Du Z. Can Radiotherapy After Breast-Conserving Surgery be Omitted in Elderly Patients with Early-Stage, Hormone-Receptor Negative Breast Cancer? A Population-Based Study and Proposed Nomogram. Adv Ther 2022. [PMID: 35953665 DOI: 10.1007/s12325-022-02279-y] [Reference Citation Analysis]
4 Wei J, Jiang Y, Shao Z. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype. Breast 2020;51:40-9. [PMID: 32200207 DOI: 10.1016/j.breast.2020.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Español A, Sanchez Y, Salem A, Obregon J, Sales ME. Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells. World J Clin Oncol 2022; 13(6): 505-519 [DOI: 10.5306/wjco.v13.i6.505] [Reference Citation Analysis]
6 Blomain ES, Moding EJ. Liquid Biopsies for Molecular Biology-Based Radiotherapy. Int J Mol Sci 2021;22:11267. [PMID: 34681925 DOI: 10.3390/ijms222011267] [Reference Citation Analysis]
7 Luz FACD, Marinho EDC, Nascimento CP, Marques LA, Duarte MBO, Delfino PFR, Antonioli RM, Araújo RA, Silva MJB. The effectiveness of radiotherapy in preventing disease recurrence after breast cancer surgery. Surg Oncol 2022;41:101709. [PMID: 35124329 DOI: 10.1016/j.suronc.2022.101709] [Reference Citation Analysis]
8 Grabarska A, Wróblewska-Łuczka P, Kukula-Koch W, Łuszczki JJ, Kalpoutzakis E, Adamczuk G, Skaltsounis AL, Stepulak A. Palmatine, a Bioactive Protoberberine Alkaloid Isolated from Berberis cretica, Inhibits the Growth of Human Estrogen Receptor-Positive Breast Cancer Cells and Acts Synergistically and Additively with Doxorubicin. Molecules 2021;26:6253. [PMID: 34684834 DOI: 10.3390/molecules26206253] [Reference Citation Analysis]
9 Español A, Salem A, Sanchez Y, Sales ME. Breast cancer: Muscarinic receptors as new targets for tumor therapy. World J Clin Oncol 2021; 12(6): 404-428 [PMID: 34189066 DOI: 10.5306/wjco.v12.i6.404] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Durrani IA, Bhatti A, John P. The prognostic outcome of 'type 2 diabetes mellitus and breast cancer' association pivots on hypoxia-hyperglycemia axis. Cancer Cell Int 2021;21:351. [PMID: 34225729 DOI: 10.1186/s12935-021-02040-5] [Reference Citation Analysis]